Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The cellular activity of several regulatory and signal transduction proteins, which depend on the Hsp90 molecular chaperone for folding, is markedly decreased by geldanamycin and by radicicol (monorden). We now show that these unrelated compounds both bind to the N-terminal ATP/ADP-binding domain of Hsp90, with radicicol displaying nanomolar affinity, and both inhibit the inherent ATPase activity of Hsp90 which is essential for its function in vivo. Crystal structure determinations of Hsp90 N-terminal domain complexes with geldanamycin and radicicol identify key aspects of their nucleotide mimicry and suggest a rational basis for the design of novel antichaperone drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Whitesell, L., Mimnaugh, E. G., De Costa, B., Myers, C. E., & Neckers, L. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8324 · Cited by 1,444
Stebbins, C. E., Russo, A. A., Schneider, C., Rosen, N., Hartl, F. U., & Pavletich, N. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80203-2 · Cited by 1,364
Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)80314-1 · Cited by 1,265
Self-citationDynamic activation of endothelial nitric oxide synthase by Hsp90
García-Cardeña, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo
Panaretou, B., Prodromou, C., Roe, S. M., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4829 · Cited by 735
Self-citationGrenert, J. P., Sullivan, W. P., Fadden, P., Haystead, T. A. J., Clark, J., Mimnaugh, E., Krutzsch, H., Ochel, H.-J., Schulte, T. W., Sausville, E., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23843 · Cited by 569
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent
Supko, J. G., Hickman, R. L., Grever, M. R., & Malspeis, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689048 · Cited by 510
Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., Binart, N., Mester, J., & Baulieu, E.-E. (1984) · Nature · doi:10.1038/308850a0 · Cited by 434
Research works printed but not linked: 15
- Kwon H. J., 1992, Biosci. Biotechnol. Biochem., 56, 539
- Zhao J. F., 1995, Oncogene, 11, 173
- Kwon H. J., 1995, J. Biochem., 118, 228
- Fukazawa H., 1991, Biochem. Pharmacol., 42, 1671
- Smith D. F., 1995, Mol. Cell. Biol., 15, 6812
- Whitesell L., 1996, Endocrinology, 10, 712
- Ali J. A., 1993, Biochemistry, 32, 2724
- Cutler H. G., 1987, Agric. Biol. Chem., 51, 3338
- Schnur R. C., 1995, J. Med. Chem., 38, 3820
- Schnur R. C., 1995, J. Med. Chem., 38, 3812
- Hartmann F., 1997, Int. J. Cancer, 70, 229, 10.1002/(SICI)1097-0215(19970117)70:2<221::AID-IJC14>3.0.CO;2-L · doi:10.1002/(sici)1097-0215(19970117)70:2<221::aid-ijc14>3.0.co;2-l
- Dai K., 1996, J. Biol. Chem., 271, 22034
- Whitesell L., 1992, Cancer Res., 52, 1728
- Prodromou C., 1996, PROTEINS: Struct. Funct. Genet., 25, 522
- Merrit E. A., 1994, Acta Crystallogr., 50, 873
Cited by
Items 601–700 of 1,000
Lombardi, R., Sonego, M., Pucci, B., Addi, L., Iannelli, F., Capone, F., Alfano, L., Roca, M. S., Milone, M. R., Moccia, T., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12883 · Cited by 20
Distinguishing mutants that resist drugs via different mechanisms by examining fitness tradeoffs
Schmidlin, K., Apodaca, S., Newell, D., Sastokas, A., Kinsler, G., & Geiler‐Samerotte, K. (2024) · eLife · doi:10.7554/elife.94144 · Cited by 18
Zierer, B. K., Weiwad, M., Rübbelke, M., Freiburger, L. A., Fischer, G. S., Lorenz, O., Sattler, M., Richter, K., & Büchner, J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201406578 · Cited by 20
Bartsch, K., Hombach, A., & Clos, J. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0800-2 · Cited by 20
Targeting hsp90 family members: A strategy to improve cancer cell death
Calderón, P. B., Beck, R., & Glorieux, C. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.010 · Cited by 20
Trivedi, J. S., Parveen, A., Rozy, F., Mitra, A., Bal, C., Mitra, D., & Sharon, A. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111699 · Cited by 20
Zhang, Y., Zhang, T., Li, X., Liang, J., Tu, S., Xu, H., Xue, W.-H., Qian, X.-H., Zhang, Z.-H., Zhang, X., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112988 · Cited by 20
Lee, S., Jung, J., Lee, Y., Kim, S., Kim, J., Kim, B., Park, K. C., Kwon, B., & Han, D. C. (2021) · Cancers · doi:10.3390/cancers13122987 · Cited by 22
Mehta, P. P., Kung, P., Yamazaki, S., Walls, M., Shen, A., Nguyen, L., Gehring, M. R., Los, G., Smeal, T., & Yin, M.-J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.002 · Cited by 20
RetractedKakar, M., Kanwal, C., Davis, J. R., Li, H., & Lim, C. S. (2006) · The AAPS Journal · doi:10.1208/aapsj080481 · Cited by 22
Discovery and development of natural heat shock protein 90 inhibitors in cancer treatment
Li, Y., Zhang, D., Xu, J. H., Shi, J.-M., Jiang, L., Yao, N., & Ye, W. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.03.009 · Cited by 20
Garfinkel, M. D., Sollars, V. E., Lu, X., & Ruden, D. M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-828-5:151 · Cited by 20
Hampel, T., Neubauer, T. M., van Leeuwen, T., & Bach, T. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201201600 · Cited by 19
Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents targeting Hsp90
Montoir, D., Barillé‐Nion, S., Tonnerre, A., Juin, P. P., Duflos, M., & Bazin, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.050 · Cited by 19
Langer, T., Schlatter, H., & Fasold, H. (2002) · Cell Biology International · doi:10.1006/cbir.2002.0882 · Cited by 19
The HSP90 and DNA topoisomerase VI inhibitor radicicol also inhibits human type II DNA topoisomerase
Gadelle, D., Graille, M., & Forterre, P. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.040 · Cited by 19
Synthesis of resorcinylic macrocycles related to radicicol via ring-closing metathesis
Cooper, T. S., Atrash, B., Sheldrake, P. W., Workman, P., & McDonald, E. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.01.117 · Cited by 19
Singh, M., Shah, V., & Tatu, U. S. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.01.008 · Cited by 19
Liu, X., Seh, C. C., & Cheung, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.053 · Cited by 18
Pedersen, N. M., Breen, K., Rødland, M. S., Haslekås, C., Stang, E., & Madshus, I. H. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2183 · Cited by 18
How Selective are Hsp90 Inhibitors for Cancer Cells over Normal Cells?
Wang, Y., Koay, Y. C., & McAlpine, S. R. (2017) · ChemMedChem · doi:10.1002/cmdc.201600595 · Cited by 19
Novel Harmicines with Improved Potency against Plasmodium
Marinović, M., Perković, I., Fontinha, D., Prudêncio, M., Held, J., de Carvalho, L. P., Tandarić, T., Vianello, R., Zorc, B., & Rajić, Z. (2020) · Molecules · doi:10.3390/molecules25194376 · Cited by 18
Violacein-Induced Chaperone System Collapse Underlies Multistage Antiplasmodial Activity
Tavella, T. A., da Silva, N. S. M., Spillman, N. J., Kayano, A. C. A. V., Cassiano, G. C., de Vasconcelos, A. A., Camargo, A. P., Baía-da-Silva, D. C., Fontinha, D., Alvarez, L. C. S., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00454 · Cited by 19
Ochel, H.-J., & Gademann, G. (2002) · Oncology Research and Treatment · doi:10.1159/000067442 · Cited by 18
Tomohiro, T., Yamamoto, A., Tatsumi, Y., & Hatanaka, Y. (2013) · Chemical Communications · doi:10.1039/c3cc45780j · Cited by 10
Geldanamycin inhibits Fas signaling pathway and protects neurons against ischemia
Yin, X., Han, Y., Zhuang, Y., Yan, J.-Z., & Li, C. V. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.05.003 · Cited by 19
Magwenyane, A. M., Mhlongo, N. N., Lawal, M. M., Amoako, D. G., Somboro, A. M., Sosibo, S. C., Shunmugam, L., Khan, R. B., & Kumalo, H. M. (2020) · Molecules · doi:10.3390/molecules25081785 · Cited by 18
Schilb, A., Riou, V., Schoepfer, J. G., Ottl, J., Müller, K., Chêne, P., Mayr, L. M., & Filipuzzi, I. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265538 · Cited by 20
Merits of Diazirine Photo-Immobilization for Target Profiling of Natural Products and Cofactors
Prokofeva, P., Höfer, S., Hornisch, M., Abele, M., Küster, B., & Médard, G. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00500 · Cited by 18
HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease
Prodromou, C., Aran-Guiu, X., Oberoi, J., Perna, L., Chapple, J. P., & van der Spuy, J. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-14740-1_13 · Cited by 22
Self-citationBelkacemi, Z., Bianciotto, M., Minoux, H., Tony Lelièvre, A., Stoltz, G., & Gkeka, P. (2023) · The Journal of Chemical Physics · doi:10.1063/5.0151053 · Cited by 17
[Modification of natural products for drug discovery].
Guo, Z. (2012) · PubMed · Cited by 17
Felder, E. R., Badari, A., Disingrini, T., Mantegani, S., Orrenius, C., Avanzi, N. R., Isacchi, A., & Salom, B. (2012) · Molecular Diversity · doi:10.1007/s11030-012-9361-6 · Cited by 17
Liang, J., Zhang, T., Li, Z., Chen, Z., Yan, X., & Meng, F. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-016-1553-7 · Cited by 17
Shadrack, D. M., Swai, H., & Hassanali, A. A. (2019) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2019.107510 · Cited by 18
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone
Batista, F. A. H., Ramos, S. L., Tassone, G., Leitão, A., Montanari, C. A., Botta, M., Mori, M., & Borges, J. C. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1726342 · Cited by 17
17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma
Singh, S. V., Abu‐Zaid, A., Lin, W., Low, J. A., Abdolvahabi, A., Jin, H., Wu, Q., Cooke, B., Fang, J., Bowling, J. J., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101996 · Cited by 20
Probing the Influence of an Allylic Methyl Group in Zearalenone Analogues on Binding to Hsp90
Rink, C., Sasse, F., Zubrienė, A., Matulis, D., & Maier, M. E. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201001752 · Cited by 17
Raman, S., Singh, M., Tatu, U. S., & Suguna, K. (2015) · Scientific Reports · doi:10.1038/srep17015 · Cited by 17
A convergent synthesis of the macrolide core of migrastatin
Baba, V. S., Das, P., Mukkanti, K., & Javed Iqbal, M. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.06.082 · Cited by 17
Thorat, D. A., Doddareddy, M. R., Seo, S. H., Hong, T.-J., Cho, Y. S., Hahn, J., & Pae, A. N. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.117 · Cited by 17
Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors
Li, Z., Jia, L., Wang, J., Wu, X., Hao, H., Wu, Y., Xu, H., Wang, Z., Shi, G., Lu, C., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.078 · Cited by 16
The natural alkaloid sanguinarine promotes the expression of heat shock protein genes in Arabidopsis
Hara, M., & Kurita, I. (2014) · Acta Physiologiae Plantarum · doi:10.1007/s11738-014-1681-y · Cited by 16
Key role of heat shock protein 90 in leptin‐induced STAT3 activation and feeding regulation
Hosoi, T., Kohda, T., Matsuzaki, S., Ishiguchi, M., Kuwamura, A., Akita, T., Tanaka, J., & Ozawa, K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13520 · Cited by 17
Fragment-Based Drug Design: Strategic Advances and Lessons Learned
Chen, H., Zhou, X., Gao, Y., Chen, H., & Zhou, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12319-4 · Cited by 20
da Silva, N. S. M., Seraphim, T. V., Minari, K., Barbosa, L. R. S., & Borges, J. C. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.161 · Cited by 16
Discovery of pseudolaric acid A as a new Hsp90 inhibitor uncovers its potential anticancer mechanism
Liu, J., Wu, X., Li, W., Yuan, Z., YANG, K. Y., & Zhao, Q. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104963 · Cited by 16
Lepvrier, E., Moullintraffort, L., Nigen, M., Goude, R., Allegro, D., Barbier, P., Peyrot, V., Thomas, D., Nazabal, A., & Garnier, C. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00051 · Cited by 17
Hsp90 as a therapeutic target in patients with oesophageal carcinoma
Ekman, S., Bergqvist, M., Tell, R., Bergström, S. N., & Lennartsson, J. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003621278 · Cited by 16
Lv, P., Xiao, Z., Fang, R.-Q., Li, H., Zhu, H., & Liu, C. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.019 · Cited by 16
Effects of Inhibitors on Hsp90′s Conformational Dynamics, Cochaperone and Client Interactions
Schmid, S., Götz, M., & Hugel, T. (2018) · ChemPhysChem · doi:10.1002/cphc.201800342 · Cited by 16
Горбачева, Л. Р., Storozhevykh, T. P., Pinelis, V. G., Давыдова, О. Н., Ishiwata, S., & Strukova, S. M. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908060138 · Cited by 16
Singh, M. K., Ranbhise, J. S., Fu, M., Ju, S., Han, S., Yun, H. R., Choe, W., Kim, S. S., & Kang, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110279 · Cited by 16
Pavić, K., Poje, G., de Carvalho, L. P., Tandarić, T., Marinović, M., Fontinha, D., Held, J., Prudêncio, M., Piantanida, I., Vianello, R., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117734 · Cited by 15
Kumalo, H. M., Bhakat, S., & Soliman, M. E. S. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12582 · Cited by 16
Xuxia, W., Jie, C., Bo, W., Lijun, L., Jiang, H., Diluo, T., & Ding-xiang, P. (2011) · Plant Molecular Biology Reporter · doi:10.1007/s11105-011-0361-y · Cited by 15
An Hsp90 modulator that exhibits a unique mechanistic profile
Ramsey, D. M., McConnell, J. R., Alexander, L. D., Tanaka, K. W., Vera, C. M., & McAlpine, S. R. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.012 · Cited by 15
Qu, S., Mulamoottil, V. A., Nayak, A., Ryu, S., Hou, X., Song, J., Yu, J., Sahu, P. K., Zhao, L., Choi, S., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.041 · Cited by 15
Wang, T., Luo, S., Qin, H., & Xia, Y. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.021 · Cited by 17
Saul, V. V., Seibert, M., Krüger, M., Jeratsch, S., Kracht, M., & Schmitz, M. (2019) · iScience · doi:10.1016/j.isci.2019.08.001 · Cited by 14
Xu, Y., Zeng, P., Wang, H., Han, K., Qiu, G., Wei, Y., Chen, R., Wang, L., & Liu, X. (2022) · Drug Development Research · doi:10.1002/ddr.21974 · Cited by 15
He, T., Lykov, N., Luo, X., Wang, H., Du, Z., Chen, Z., Chen, S., Zhu, L., Zhao, Y., & Tzeng, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032053 · Cited by 17
Targeting Heat Shock Protein 90 for Malaria
Ramdhave, A. S., Patel, D., Ramya, I., Nandave, M., & Kharkar, P. S. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/13895575113136660094 · Cited by 17
Macrolactam analogues of macrolide natural products
Hügel, H., SMITH, A. T., & Rizzacasa, M. A. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob02149b · Cited by 15
Mettu, A., Talla, V., Bajaj, D. M., & Subhashini, N. J. P. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201900063 · Cited by 15
CgSTE11 mediates cross tolerance to multiple environmental stressors in Candida glabrata
Huang, M., Khan, J. A., Kaur, M., Torres-Vanegas, J. D., Patiño, O. A. A., Ramasubramanian, A. K., & Kao, K. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53593-5 · Cited by 15
Reigan, P., Siegel, D. M., Guo, W., & Ross, D. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070086 · Cited by 15
The ATPases: a new family for a family-based drug design approach
Chêne, P. (2003) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.7.3.453 · Cited by 16
Yamamoto, K., Garbaccio, R. M., Stachel, S. J., Solit, D. B., Chiosis, G., Rosen, N. X., & Danishefsky, S. J. (2003) · Angewandte Chemie · doi:10.1002/ange.200390300 · Cited by 15
Detecting Posttranslational Modifications of Hsp90
Sager, R., Woodford, M. R., Neckers, L., & Mollapour, M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7477-1_16 · Cited by 14
Magni, S., Succurro, A., Skupin, A., & Ebenhöh, O. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0965 · Cited by 16
Jung, J., Kwon, J., Hong, S.-J., Moon, A.-N., Jeong, J., Kwon, S., Kim, J., Lee, M., Lee, H. S., Lee, J. H., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127165 · Cited by 14
Gaonkar, R., Singh, J., Chauhan, A., Avti, P., & Hegde, G. (2021) · Phytochemistry · doi:10.1016/j.phytochem.2021.113058 · Cited by 14
Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy
de Keijzer, M. J., de Klerk, D. J., de Haan, L. R., van Kooten, R. T., Franchi, L. P., Dias, L. M., Kleijn, T. G., van Doorn, D. J., Heger, M., & on behalf of the Photodynamic Therapy Study Group (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2099-1_19 · Cited by 14
Drug–target identification from total cellular lysate by drug-induced conformational changes
Nishiya, Y., Shibata, K., Saito, S., Yano, K., Oneyama, C., Nakano, H., & Sharma, S. V. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.11.034 · Cited by 17
Propionate Analogues of Zearalenone Bind to Hsp90
Ugele, M., Sasse, F., Knapp, S., Fedorov, O., Zubrienė, A., Matulis, D., & Maier, M. E. (2009) · ChemBioChem · doi:10.1002/cbic.200900109 · Cited by 14
Cellular Assays for Drug Discovery in Genetic Disorders of Intracellular Trafficking
Matteis, M. A. D., Vicinanza, M., Venditti, R., & Wilson, C. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153415 · Cited by 17
Skrzypczak, N., Pyta, K., Ruszkowski, P., Gdaniec, М., Bartl, F. J., & Przybylski, P. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112624 · Cited by 14
Mikhailova, E., Sokolenko, A., Combs, S. E., & Shevtsov, M. A. (2025) · Cells · doi:10.3390/cells14130979 · Cited by 14
BGP-15 improves contractile function of regenerating soleus muscle
Nascimento, T. L., da Silva, M. T., & Miyabara, E. H. (2018) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-018-9495-y · Cited by 14
Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment
Donahue, K., Xie, H., Li, M., Gao, A., Ma, M., Wang, Y., Tipton, A. R., Semanik, N., Primeau, T. M., Li, S., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102700 · Cited by 14
Seaton, A., Maxwell, P., Hill, A., Gallagher, R., Pettigrew, J., Wilson, R. H., & Waugh, D. J. J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605356 · Cited by 13
Sohn, M., Noh, H.-J., Yoo, I., & Kim, W. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.01.054 · Cited by 13
Enantiodivergent routes to (+) and (−)-novioses from (−)-pantolactone
Rajesh, B. M., Shinde, M. V., Kannan, M., Srinivas, G., Iqbal, J., & Reddy, D. S. (2013) · RSC Advances · doi:10.1039/c3ra42891e · Cited by 13
A Review of MED-SuMo Applications
Doppelt‐Azeroual, O., Moriaud, F., Adcock, S. A., & Delfaud, F. (2009) · Infectious Disorders - Drug Targets · doi:10.2174/1871526510909030344 · Cited by 13
Structure based design of heat shock protein 90 inhibitors acting as anticancer agents
Doddareddy, M. R., Thorat, D. A., Seo, S. H., Hong, T.-J., Cho, Y. S., Hahn, J., & Pae, A. N. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.023 · Cited by 13
Heat Shock Protein 90 Regulates Development in Dictyostelium discoideum
Sawarkar, R., Roy, N., Rao, S., Raman, S., Sivaramakrishnan, V., Suguna, K., & Tatu, U. S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.006 · Cited by 13
Kawaguchi, K., Saito, H., Okazaki, S., & Nagao, H. (2013) · Chemical Physics Letters · doi:10.1016/j.cplett.2013.10.015 · Cited by 16
Olesen, S. H., Ingles, D. J., Zhu, J.-Y., Martin, M. P., Betzi, S., Georg, G. I., Tash, J. S., & Schönbrunn, E. (2015) · Molecules · doi:10.3390/molecules20011643 · Cited by 13
Spichty, M., Taly, A., Hagn, F., Kessler, H., Barluenga, S., Winssinger, N., & Karplus, M. (2009) · Biophysical Chemistry · doi:10.1016/j.bpc.2009.04.003 · Cited by 13
Modular Asymmetric Synthesis of Aigialomycin D, a Kinase‐Inhibitory Scaffold
Barluenga, S., Dakas, P., Ferandin, Y., Meijer, L., & Winssinger, N. (2006) · Angewandte Chemie · doi:10.1002/ange.200600593 · Cited by 13
Synthesis of Hsp90 inhibitor dimers as potential antitumor agents
Muranaka, K., Sano, A., Ichikawa, S., & Matsuda, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.070 · Cited by 13
Hardcastle, A., Boxall, K. J., Richards, J., Tomlin, P., Sharp, S. Y., Clarke, P. A., Workman, P., & Aherne, W. (2005) · Assay and Drug Development Technologies · doi:10.1089/adt.2005.3.273 · Cited by 16
Hardcastle, A., Tomlin, P., Norris, C., Richards, J., Cordwell, M., Boxall, K. J., Rowlands, M., Jones, K., Collins, I., McDonald, E., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0496 · Cited by 13
The Hsp90 chaperone complex-A potential target for cancer therapy
Darimont, B. D. (1999) · World Journal of Gastroenterology · doi:10.3748/wjg.v5.i3.195 · Cited by 13
Total Synthesis and Structural Revision of Monocillin VII
Mallampudi, N. A., Srinivas, B., Reddy, J. G., & Mohapatra, D. K. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b02075 · Cited by 12
Rao, H. S. P., Rafi, S., Kumar, P., Chakibanda, G., & Muthanna, N. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2012.09.065 · Cited by 12
Trypanosome Prereplication Machinery: A Potential New Target for an Old Problem
Calderano, S. G., Godoy, P. D. D. M., da Cunha, J. P. C., & Elias, M. C. (2011) · Enzyme Research · doi:10.4061/2011/518258 · Cited by 12
Yan, F., Liu, X., Zhang, S., Zhang, Q., & Chen, J. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13623 · Cited by 12
Nakamoto, H., Yokoyama, Y., Suzuki, T., Miyamoto, Y., Fujishiro, T., Morikawa, M., & Miyata, Y. (2021) · The Journal of Biochemistry · doi:10.1093/jb/mvab037 · Cited by 12
Metadata
- Authors
- Roe, S. M., Prodromou, C., O'Brien, R., Ladbury, J. E., Piper, P. W., & Pearl, L. H.
- Affiliations
- University College London (GB)
- Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, U.K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-01-01
- Volume
- 42
- Issue
- 2
- Pages
- 260-266
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2042699875
- Cited by
- 1,004
- References
- 26
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 25 · 2023: 17 · 2022: 24 · 2021: 23 · 2020: 38 · 2019: 45 · 2018: 32 · 2017: 23 · 2016: 35 · 2015: 43 · 2014: 47 · 2013: 31 · 2012: 50
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- HSP90, molecular chaperones, geldanamycin, radicicol, antitumor antibiotics, ATPase inhibition, protein folding
- MeSH terms
- Adenosine Diphosphate, Adenosine Triphosphatases, Antibiotics, Antineoplastic, Calorimetry, Lactones, Models, Molecular, Quinones, Structure-Activity Relationship, Benzoquinones, Crystallography, X-Ray, Molecular Mimicry, HSP90 Heat-Shock Proteins, Macrolides, Lactams, Macrocyclic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.